Your session is about to expire
← Back to Search
Mobile Interventions for Suicide
N/A
Waitlist Available
Led By Kirsten H Dillon, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-mist assessment visit (approximately one month after enrollment)
Awards & highlights
Study Summary
This trial will develop and test a mobile intervention to reduce thoughts that contribute to suicide risk, with the goal of improving suicide risk and functioning.
Who is the study for?
This trial is for U.S. veterans aged 18 or older who have PTSD, experience anger and suicidal thoughts but without immediate intent to harm themselves or others. They must be able to read at a sixth-grade level and should be actively engaged in mental health treatment. Veterans with bipolar, psychotic disorders, imminent suicide risk, homicidal ideation, or current substance use disorder cannot participate.Check my eligibility
What is being tested?
The study is testing two mobile apps: MIST aims to reduce suicidal thoughts by changing negative beliefs about oneself while MIRA focuses on managing anger. The effectiveness of these apps will be measured by their ability to lower the risk of suicide and improve overall functioning in participants.See study design
What are the potential side effects?
Since this trial involves psychological interventions through mobile applications rather than medications, traditional side effects are not expected. However, discussing sensitive topics like suicide and anger may cause emotional discomfort.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion (approximately 10 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion (approximately 10 months)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
MIST App utilization
Number of participants recruited
Patient satisfaction or MIST app: Client Satisfaction Questionnaire
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: MIST intervention followed by MIRA interventionExperimental Treatment2 Interventions
These are both mobile interventions that use interpretation bias modification (IBM) techniques to reduce cognitive biases. The MIST app targets suicidal cognitions and the MIRA app targets hostile interpretation bias (which contributes to anger). The MIRA application has already been developed, but the MIST application is newly developed based on the same procedures. All participants will complete the MIST intervention and provide feedback so that we can refine it. We will also be collecting EMA data on to examine how changes to suicide cognitions and hostile interpretation bias (by use of the two apps) affects suicidal ideation and functioning.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mobile Intervention for Suicidal Thoughts (MIST)
2021
N/A
~10
Mobile Intervention for Reducing Anger (MIRA)
2021
N/A
~50
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,593 Total Patients Enrolled
38 Trials studying Suicide
5,608 Patients Enrolled for Suicide
Kirsten H Dillon, PhDPrincipal InvestigatorDurham VA Medical Center, Durham, NC
2 Previous Clinical Trials
187 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have been diagnosed with bipolar or psychotic disorder.You are currently at high risk of trying to harm yourself or someone else, and need immediate help.You currently have a problem with drugs or alcohol.
Research Study Groups:
This trial has the following groups:- Group 1: MIST intervention followed by MIRA intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Has recruitment for this investigation commenced?
"Per information on clinicaltrials.gov, this medical investigation is actively recruiting participants who fit the criteria. It was listed for the first time on December 1st 2021 and has been revised most recently on November 2nd 2022."
Answered by AI
How many individuals are enrolled in this research endeavor?
"Affirmative. Clinicaltrials.gov details indicate that this clinical trial, which was initially posted on December 1st 2021, is currently enrolling patients. The aim of the study is to recruit 10 participants from a single medical centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger